Drug intelligence / Profile preview

sodium hyaluronate + amino acids

Development stage
Unknown
Lead developer
NTC Pharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Sodium hyaluronate + amino acids is a combination ophthalmic solution designed for the treatment of dry eye syndrome and the promotion of ocular surface recovery following surgery, such as cataract extraction. Sodium hyaluronate, a high-molecular-weight glycosaminoglycan, acts as a potent lubricant and humectant that stabilizes the tear film and protects the corneal endothelium. The amino acid component—typically consisting of glycine, L-proline, L-lysine, and L-leucine—serves as a nutritional substrate for the corneal epithelium, supporting cellular metabolism, protein synthesis, and wound healing processes. By combining mechanical lubrication with metabolic support, the formulation helps alleviate postoperative discomfort, reduce inflammation, and accelerate the restoration of ocular surface integrity.

Brand names
Helenvision ultraAminodropHyalistil Bio
Other names
sodium hyaluronate 0.2% and amino acidsSH-AA ophthalmic solution
02

Targets

STAB2 (Stabilin-2)ICAM1 (Intercellular Adhesion Molecule 1)RHAMM (Hyaluronan-mediated motility receptor)LYVE1 (Lymphatic vessel endothelial hyaluronic acid receptor 1)CD44 (CD44 antigen)

Beyond the preview

Go deeper on sodium hyaluronate + amino acids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium hyaluronate + amino acids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call